Introduction: to report a case of bilateral leukemic retinopathy due to leukostasis that was successfully managed by leukapheresis.
Chronic Myelogenous Leukemia (CML) which is also known as Chronic Myeloid
Leukemia is a myeloproliferative disorder characterized by increased proliferation of granulocyte cells. CML occupies 20% of all leukemia in adults. 1 The white blood cell counts of patients diagnosed with chronic myeloid leukemia (CML) vary greatly. Study by Koshy et al., revealed that leukemic ophthalmic lesions were found in 43.8% patients with acute and chronic leukemias. Ocular involvement is more often seen in adults, acute and myeloid leukemias. 2 Leukostasis is characterized by the occlusion of the microvasculature by white blood cells. 3 We report the case of a previously healthy man with mild visual loss, striking fundus changes, and an extremely high white blood cell count who had significant recovery of vision after leukapheresis.
CASE PRESENTATION
A 31-year-old man was diagnosed blast phase of CML from internal medicine department and referred to ophthalmology department after reporting mild visual loss in both eyes for 3 months. Additional history revealed epistaxis, back pain, night sweats, and weight loss. A complete blood count revealed white blood cell (WBC) count of 533.900/mm3 (reference range: 3.500 to 11.000/mm3), platelet count of 139.000 (reference range: 150.000 to 400.000/mm3), and hemoglobin concentration of 8.7 g/dL (reference range: 14-18 g/dL). 
CONCLUSION
This case report underlined the importance of routine eye examinations in patients with leukemia and vice versa in healthy patients with signs of leukemic retinopathy to complete blood tests and referral to hematologist for further management, because the key is to treat the underlying malignancy. 
